Simon May's most recent trade in Bio-Rad Laboratories Inc. - Ordinary Shares - Class A was a trade of 3,535 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on March 8, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 3,535 | 3,535 | - | - | Non-Qualified Stock Option (right to buy) | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2023 | 3,005 | 3,005 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 3,399 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 600 | 0 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 526 | 2,981 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 526 | 526 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 1,562 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 520 | 2,126 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 409 | 410 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 409 | 2,597 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 371 | 744 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2023 | 371 | 2,317 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 295 | 3,104 (0%) | 0% | 394.6 | 116,407 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 182 | 2,799 (0%) | 0% | 394.6 | 71,817 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 180 | 1,946 (0%) | 0% | 394.6 | 71,028 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 142 | 2,455 (0%) | 0% | 394.6 | 56,033 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 394.60 per share. | 01 Sep 2023 | 129 | 2,188 (0%) | 0% | 394.6 | 50,903 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 1,848 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 0 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 600 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 600 | 1,533 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 526 | 1,052 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 526 | 1,115 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 409 | 819 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2022 | 409 | 731 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 298 | 1,550 (0%) | 0% | 478.3 | 142,539 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 285 | 1,248 (0%) | 0% | 478.3 | 136,321 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 182 | 933 (0%) | 0% | 478.3 | 87,054 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 478.32 per share. | 02 Sep 2022 | 142 | 589 (0%) | 0% | 478.3 | 67,921 | Bio-Rad A Common Stock |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 2,082 | 2,082 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 371 | 1,115 | - | - | Restricted Stock Units | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 371 | 451 (0%) | 0% | 0 | Bio-Rad A Common Stock | |
Bio-Rad Laboratories Inc. ... | Simon May | EVP, President, LSG | Payment of exercise price or tax liability using portion of securities received from the company at price $ 486.25 per share. | 01 Sep 2022 | 129 | 322 (0%) | 0% | 486.2 | 62,726 | Bio-Rad A Common Stock |